Further suppression of Wee1 not only causes cell cycle arrest and inhibits the proliferation of cancer cells but also enhances CML cell sensitivity to Imatinib in vitro and in vivo, possibly through an excessive accumulation of overall DSBs. The gene discussed is WEE1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.